Non-CME Promotional Programs
|
| Monday, October 27 6:00 pm – 10:00 pm Marriott Downtown |
Eisai, Inc.
Framing DVT: A Fresh Perspective on Thrombosis
Presented in a gallery setting, attendees will take a tour through a collection of posters displaying clinical data on low-molecular-weight heparin. Several renowned experts will speak at the event and offer what promises to be a highly enlightening question and answer session. Attendees also will enjoy a light meal and refreshments.
MD Primer, Inc.
Pulmonary Dilemmas: Vignettes in Three Challenging Pulmonary Diseases
Challenges in Interstitial Lung Disease
Paul W. Noble, MD, FCCP
Pulmonary Arterial Hypertension: Where Are We in 2008?
Richard Channick, MD, FCCP
The Pulmonary Arterial Hypertension Quality Enhancement Research Initiative:
Do Guidelines Affect Clinical Practice?
Vallerie V. McLaughlin, MD, FCCP
Acute Pulmonary Embolism: When Should We Get Aggressive?
Victor F. Tapson, MD, FCCP
In between the presentations, there will be plenty of time for questions and answers.
A number of challenging dilemmas in pulmonary medicine frequently vex the clinician. Interstitial lung disease, pulmonary arterial hypertension, and venous thromboembolismare some of the diseases causing these dilemmas. Our goal will be to offer a concise overview of each of these potentially fatal pulmonary diseases and leave the attendee with some pearls to help with the management of these patients. There will be presentation of recent data, as well as reinforcement of less recent,but crucial, information. Please note that this is a non-CME event.
A buffet dinner will be served at 6:00 pm, and the meeting will start at 7:00 pm.
To register and for more details, please visit www.mdprimer.com/chest.
sanofi-aventis
DVT/PE Quality Measures: What Happens if You Don’t Make the Leap?
At this non-CME event, commercially supported by sanofi-aventis, the new Joint Commission/National Quality Forum standards for DVT and appropriate DVT/PE prophylaxis will be discussed. The symposium features a DVT/PE health-care quality overview, appropriate DVT/PE prophylaxis, and action planning for your hospital. Faculty speakers are Samuel Z. Goldhaber, MD, FCCP; Darrell W. Harrington, MD; and Frank A. Michota, Jr., MD.
Sepracor, Inc.
Guideline-Based Management of Respiratory Disease
This program will provide a brief overview of COPD and asthma disease states and the management of these diseases according to internationally recognized guidelines. In addition, you will learn about a novel approach for using harmonicas to benefit the health of patients with respiratory diseases.
Topics that will be discussed in detail include:
- Short-Acting Beta-Agonist for Asthma and COPD
- Long-Acting Beta-Agonist for COPD
- NEW Inhaled Corticosteroids for Persistent Asthma and Seasonal and Perennial Allergic Rhinitis
SonoSite
Experience the Difference: An Evening of Ultrasound Innovation With SonoSite
On behalf of SonoSite, you are cordially invited to participate in an evening of clinical and technology trends in hand-carried ultrasound and their impact on medical practice at the point of patient care. The event will provide an opportunity for a lively exchange of information and ideas on topics including critical care ultrasound applications, patient safety, implementation, and reimbursement. There also will be a Question and Answer Corner with the experts! Want more? The evening will be completed with SonoSite technology exhibits and scanning demonstrations. Come experience the difference! Hors d'oeuvres and refreshments will be served.
For more information, visit http://www.sonosite.com/events/chest2008/.
| Tuesday, October 28 6:00 pm – 10:00 pm Marriott Downtown |
AstraZeneca LP
The Interface of Art and Science in Practical Asthma Management
At this non-CME event, an expert panel of national thought leaders will examine the multiple overlapping syndromes collectively called asthma, delve into emerging research regarding asthma phenotypes, and explore the merits of bronchoprovocation and noninvasive biomarkers (exhaled nitric oxide [FeNO], sputum eosinophils, exhaled breath condensate [EBC]) in the assessment of asthma-related hyperresponsiveness in inflammation.
This event is by invitation only. Invited guests may preregister by visiting our Web site at www.lunghealthonline.com/CHEST08.
Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc.
COPD: What Are the Next Questions We Should Be Asking To Improve the Care of Our Patients?
An Expert Panel Offers Insights Into Effective Treatment
In this non-CME symposium, an expert panel of national thought leaders will explore critical components and questions regarding the long-term management of patients with COPD, which include hyperinflation, the impact of deconditioning and activity limitation, the importance of pulmonary rehabilitation, and benefits of pharmacologic treatment.
Edwards Lifesciences, LLC
An Interactive Evening Discussing Critical Care Cases
Join us for a special dinner event and engage with a panel of experts to discuss relevant cases and topics in critical care, including methods to determine preload responsiveness, goal-directed therapies using less invasive monitoring, and application through the use of a management scheme.
Tuesday, October 28 6:00 pm – 9:30 pm, Liberty Ballroom, Marriott Downtown
Our distinguished panelists and agenda include:
Case #1: Is That Patient ‘Wet’? Why Preload Is Not Equivalent to Preload Responsiveness
Thomas L. Higgins, MD, MBA
Chief, Critical Care Division; Baystate Medical Center; Professor of Medicine and
Surgery; Associate Professor of Anesthesiology; Tufts University School of Medicine
Case #2: Which Endpoint Do We Use? Applying Goal-Directed Therapy
Jorge Guzman, MD
Director, Medical Intensive Care Unit; Pulmonary, Allergy and Critical Care Medicine; Cleveland Clinic
Application: What To Do Next: A Universal Management Scheme
Vicente H. Gracias, MD, FCCP
Associate Professor of Surgery, Section Chief Surgical Critical Care, Medical Director Critical
Care, Hospital University of Pennsylvania
Please RSVP to CriticalCare@Edwards.com (requested but not required). Dinner is complimentary.
Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc
DORIBAX™ Poster Dessert Reception
Ortho-McNeil-Janssen Pharmaceuticals, Inc is pleased to invite you to the DORIBAX™ Poster Dessert Reception. Please join us on Tuesday, October 28, 2008, from 6:00 pm - 10:00 pm at the Marriott Downtown, Grand Ballroom-Salon H, I, and J. During the reception, we will display scientific posters previously presented at various national and international congresses. These posters will update you on some of the latest and most exciting research involving DORIBAX™.
United Therapeutics
Pulmonary Arterial Hypertension: The Great Debate
There are many opinions about pulmonary arterial hypertension (PAH) and its treatments. Listen as “party leaders” make their cases during a symposium sponsored by United Therapeutics titled, “PAH: The Great Debate.” The format for this timely, election-style debate symposium will be unlike anything you’ve seen before. You will participate in grilling the candidates and select the most compelling arguments for either status quo or change. PAH heavyweights will present the data, dispute the claims, and rebut the opposition. We live in a democratic society, so you will be asked to vote on the arguments throughout the meeting. Watch the sparks fly on October 28, 2008, from 6:00 pm to 10:00 pm. Remember, every vote counts!
 |
||
|
||
|
||
|
||
|